BVF as of March 31, 2025
Portfolio Holdings for BVF
BVF holds 51 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 31.5 | $772M | 20M | 39.07 | |
| Axsome Therapeutics (AXSM) | 8.0 | $197M | 1.7M | 116.63 | |
| Revolution Medicines (RVMD) | 7.2 | $176M | 5.0M | 35.36 | |
| Kymera Therapeutics (KYMR) | 5.8 | $141M | 5.2M | 27.37 | |
| Mirum Pharmaceuticals (MIRM) | 5.1 | $126M | 2.8M | 45.05 | |
| Protagonist Therapeutics (PTGX) | 5.1 | $125M | 2.6M | 48.36 | |
| Gh Research Ordinary Shares (GHRS) | 4.0 | $97M | 8.8M | 11.03 | |
| Xoma Royalty Corporation Com New (XOMA) | 2.4 | $60M | 3.0M | 19.93 | |
| Ionis Pharmaceuticals (IONS) | 2.4 | $58M | 1.9M | 30.17 | |
| Zymeworks Del (ZYME) | 2.1 | $51M | 4.3M | 11.91 | |
| Kura Oncology (KURA) | 2.1 | $51M | 7.8M | 6.60 | |
| Cullinan Oncology (CGEM) | 1.8 | $44M | 5.8M | 7.57 | |
| Ac Immune Sa SHS (ACIU) | 1.5 | $37M | 20M | 1.87 | |
| Tyra Biosciences (TYRA) | 1.5 | $37M | 3.9M | 9.30 | |
| Galapagos Nv Spon Adr (GLPG) | 1.5 | $37M | 1.5M | 25.12 | |
| Celcuity (CELC) | 1.4 | $35M | 3.5M | 10.11 | |
| Verve Therapeutics (VERV) | 1.3 | $32M | 6.9M | 4.57 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.2 | $31M | 1.8M | 17.31 | |
| Xencor (XNCR) | 1.2 | $29M | 2.7M | 10.64 | |
| Monte Rosa Therapeutics (GLUE) | 1.1 | $26M | 5.7M | 4.64 | |
| Septerna (SEPN) | 1.0 | $26M | 4.4M | 5.79 | |
| Eledon Pharmaceuticals (ELDN) | 0.9 | $21M | 6.3M | 3.39 | |
| Cidara Therapeutics Com New (CDTX) | 0.8 | $20M | 925k | 21.54 | |
| Olema Pharmaceuticals (OLMA) | 0.8 | $20M | 5.3M | 3.76 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.8 | $20M | 697k | 27.99 | |
| Foghorn Therapeutics (FHTX) | 0.8 | $19M | 5.3M | 3.65 | |
| Iteos Therapeutics | 0.7 | $18M | 3.1M | 5.97 | |
| 4d Molecular Therapeutics In (FDMT) | 0.6 | $15M | 4.6M | 3.23 | |
| Essa Pharma Com New (EPIX) | 0.6 | $14M | 8.7M | 1.58 | |
| Annexon (ANNX) | 0.6 | $14M | 7.0M | 1.93 | |
| Verastem Com New (VSTM) | 0.5 | $13M | 2.1M | 6.03 | |
| Rapt Therapeutics | 0.5 | $11M | 9.2M | 1.22 | |
| Repare Therapeutics Ord (RPTX) | 0.4 | $10M | 10M | 0.99 | |
| Immunic (IMUX) | 0.4 | $9.7M | 8.9M | 1.09 | |
| Avalo Therapeutics Com New (AVTX) | 0.3 | $8.3M | 1.0M | 8.01 | |
| Third Harmonic Bio (THRD) | 0.3 | $8.2M | 2.4M | 3.47 | |
| Vigil Neuroscience (VIGL) | 0.3 | $7.1M | 4.0M | 1.78 | |
| Tscan Therapeutics (TCRX) | 0.3 | $6.7M | 4.9M | 1.38 | |
| Molecular Partners Ads (MOLN) | 0.2 | $5.5M | 1.4M | 4.07 | |
| Ikena Oncology (IKNA) | 0.2 | $5.1M | 4.0M | 1.28 | |
| Forte Biosciences Com New (FBRX) | 0.2 | $4.6M | 594k | 7.76 | |
| Allakos | 0.2 | $3.8M | 17M | 0.23 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $3.3M | 5.2M | 0.64 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $2.2M | 340k | 6.55 | |
| Inventiva Sa Ads (IVA) | 0.1 | $2.1M | 686k | 3.00 | |
| Glycomimetics | 0.1 | $2.0M | 9.5M | 0.21 | |
| Sab Biotherapeutics Com New (SABS) | 0.1 | $1.2M | 918k | 1.35 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.0 | $1.2M | 59k | 20.47 | |
| Ovid Therapeutics (OVID) | 0.0 | $1.2M | 3.9M | 0.31 | |
| Engene Holdings *w Exp 10/31/202 (ENGNW) | 0.0 | $605k | 945k | 0.64 | |
| Nls Pharmaceutics Com New (NLSP) | 0.0 | $221k | 144k | 1.54 |
